GIRI GI Research Institute

Vancouver V6Z 2K5

0 studies enrolling now · 5 studies all time

What they study most

Chronic Hepatitis B, Fibrostenotic Crohn's Disease, Hepatitis C, Chronic, Non Alcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis

Studies at this site

• STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed